Literature DB >> 15931549

Black diaphragm aniridia intraocular lens for aniridia and albinism.

Victoria W Y Wong1, Philip T H Lam, Timothy Y Y Lai, Dennis S C Lam.   

Abstract

BACKGROUND: Our aim was to assess the safety and efficacy of primary and secondary implantation of a black diaphragm aniridia intraocular lens (IOL) in patients that lacked a complete iris diaphragm.
METHODS: This was a retrospective non-comparative study of six eyes in five patients with iris defects. The causes of such defects included congenital aniridia, traumatic aniridia, and oculocutaneous albinism. Three eyes underwent primary implantations of a black diaphragm IOL, and three eyes were given secondary implantations. The visual acuity, subjective severity of glare, postoperative anatomical outcome and any intraoperative or postoperative complications were reviewed.
RESULTS: The mean follow-up period was 20.6 months (range 3-29 months). All patients showed stable or improvement in best-corrected visual acuity postoperatively. Glare and photophobia had improved subjectively in all patients after implantation of the black diaphragm IOL. Intraoperative complication included one case of hyphaema and iris damage during insertion of the IOL. Postoperative complications included intraocular inflammation with choroidal detachment, secondary glaucoma, and persistent epithelial defect after surgery. None of the patients developed decentration of IOL after surgery.
CONCLUSION: The black diaphragm aniridia IOL is useful in the management of the condition in patients with iris deficiency including oculocutaneous albinism. Intraoperative and postoperative complications are not uncommon, and patients should be monitored carefully in the perioperative period.

Entities:  

Mesh:

Year:  2004        PMID: 15931549     DOI: 10.1007/s00417-004-1058-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  Clinical features of affected males with X linked ocular albinism.

Authors:  S J Charles; J S Green; J W Grant; J R Yates; A T Moore
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

2.  Black diaphragm intraocular lens in congenital aniridia.

Authors:  T Sundmacher; T Reinhard; C Althaus
Journal:  Ger J Ophthalmol       Date:  1994-08

3.  Black diaphragm aniridia intraocular lens for congenital aniridia: long-term follow-up.

Authors:  T Reinhard; S Engelhardt; R Sundmacher
Journal:  J Cataract Refract Surg       Date:  2000-03       Impact factor: 3.351

4.  Implantation of a black diaphragm intraocular lens for traumatic aniridia.

Authors:  C G Thompson; K Fawzy; I G Bryce; B A Noble
Journal:  J Cataract Refract Surg       Date:  1999-06       Impact factor: 3.351

5.  Prosthetic iris implantation for congenital, traumatic, or functional iris deficiencies.

Authors:  S E Burk; A P Da Mata; M E Snyder; R J Cionni; J S Cohen; R H Osher
Journal:  J Cataract Refract Surg       Date:  2001-11       Impact factor: 3.351

6.  Lamellar intrastromal corneal tattoo for treating iris defects (artificial iris)

Authors:  T E Burris; D K Holmes-Higgin; T A Silvestrini
Journal:  Cornea       Date:  1998-03       Impact factor: 2.651

7.  Black-diaphragm intraocular lens for correction of aniridia.

Authors:  R Sundmacher; T Reinhard; C Althaus
Journal:  Ophthalmic Surg       Date:  1994-03

8.  Ocular surface abnormalities in aniridia.

Authors:  K Nishida; S Kinoshita; Y Ohashi; Y Kuwayama; S Yamamoto
Journal:  Am J Ophthalmol       Date:  1995-09       Impact factor: 5.258

  8 in total
  3 in total

1.  Black Diaphragm Intraocular Lens Implantation in Patients with Aniridia.

Authors:  Sultan H Al-Rashidi
Journal:  J Ophthalmic Vis Res       Date:  2019 Jan-Mar

2.  Iris phenotypes and pigment dispersion caused by genes influencing pigmentation.

Authors:  Michael G Anderson; Norman L Hawes; Colleen M Trantow; Bo Chang; Simon W M John
Journal:  Pigment Cell Melanoma Res       Date:  2007-06-28       Impact factor: 4.693

3.  Genetic modulation of the iris transillumination defect: a systems genetics analysis using the expanded family of BXD glaucoma strains.

Authors:  Shankar Swaminathan; Hong Lu; Robert W Williams; Lu Lu; Monica M Jablonski
Journal:  Pigment Cell Melanoma Res       Date:  2013-05-13       Impact factor: 4.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.